← FDA DRUG APPROVALS

FDA ANDA · ANDA078623

ALBUTEROL SULFATE

Sponsor: APOTEX INC

APPLICATION
ANDA078623
TYPE
ANDA
ORIGINAL APPROVAL
2010-04-05
LATEST ACTION
2023-02-02
ROUTE
INHALATION
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

ALBUTEROL SULFATEDiscontinued
ALBUTEROL SULFATE EQ 0.021% BASE · SOLUTION · INHALATION
ALBUTEROL SULFATEDiscontinued
ALBUTEROL SULFATE EQ 0.042% BASE · SOLUTION · INHALATION

Approval history

2023-02-02Labeling · Supplement 2 · standardAP
2014-02-28Labeling · Supplement 1 · standardAP
2010-04-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →